Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Arthritis and Rheumatism
|
August 1, 2008
A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome
Raphaela Goldbach-Mansky, Sharukh D Shroff, Mildred Wilson, et al.
Journal of Medicinal Chemistry
|
March 16, 2013
Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres
Xiaofang Wang, Yuxiang Dong, Sergio Wittlin, et al.
Journal of Primary Care & Community Health
|
August 22, 2025
A Retrospective Comparative Study of Sex-Based Risk Variations in Heart Failure With Preserved Ejection Fraction (HFpEF) Versus Heart Failure With Reduced Ejection Fraction (HFrEF)
Kristen Yeh, Mariam Ansar, Hera Jamal, et al.
Annals of Internal Medicine
|
August 19, 2009
Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial
Raphaela Goldbach-Mansky, Mildred Wilson, Roy Fleischmann, et al.
Bioorganic & Medicinal Chemistry
|
June 9, 2006
Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanes
Yuxiang Dong, Yuanqing Tang, Jacques Chollet, et al.
Journal of Medicinal Chemistry
|
July 22, 2005
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes
Yuxiang Dong, Jacques Chollet, Hugues Matile, et al.
Journal of Medicinal Chemistry
|
November 21, 2009
The structure-activity relationship of the antimalarial ozonide arterolane (OZ277)
Yuxiang Dong, Sergio Wittlin, Kamaraj Sriraghavan, et al.
Annals of the Rheumatic Diseases
|
June 8, 2014
A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease
Cailin H Sibley, Andrea Chioato, Sandra Felix, et al.
Journal of Medicinal Chemistry
|
February 1, 2008
Malaria-infected mice are cured by oral administration of new artemisinin derivatives
Gary H Posner, Wonsuk Chang, Lindsey Hess, et al.
The Journal of Surgical Research
|
May 21, 2026
Risks for Recurrence After Pediatric Primary Spontaneous Pneumothorax: Results From a Multicenter Study
Abigail J Engwall-Gill, Katrina Morgan, Jennine H Weller, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Arthritis and Rheumatism
|
August 1, 2008
A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome
Raphaela Goldbach-Mansky, Sharukh D Shroff, Mildred Wilson, et al.
Journal of Medicinal Chemistry
|
March 16, 2013
Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres
Xiaofang Wang, Yuxiang Dong, Sergio Wittlin, et al.
Journal of Primary Care & Community Health
|
August 22, 2025
A Retrospective Comparative Study of Sex-Based Risk Variations in Heart Failure With Preserved Ejection Fraction (HFpEF) Versus Heart Failure With Reduced Ejection Fraction (HFrEF)
Kristen Yeh, Mariam Ansar, Hera Jamal, et al.
Annals of Internal Medicine
|
August 19, 2009
Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial
Raphaela Goldbach-Mansky, Mildred Wilson, Roy Fleischmann, et al.
Bioorganic & Medicinal Chemistry
|
June 9, 2006
Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanes
Yuxiang Dong, Yuanqing Tang, Jacques Chollet, et al.
Journal of Medicinal Chemistry
|
July 22, 2005
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes
Yuxiang Dong, Jacques Chollet, Hugues Matile, et al.
Journal of Medicinal Chemistry
|
November 21, 2009
The structure-activity relationship of the antimalarial ozonide arterolane (OZ277)
Yuxiang Dong, Sergio Wittlin, Kamaraj Sriraghavan, et al.
Annals of the Rheumatic Diseases
|
June 8, 2014
A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease
Cailin H Sibley, Andrea Chioato, Sandra Felix, et al.
Journal of Medicinal Chemistry
|
February 1, 2008
Malaria-infected mice are cured by oral administration of new artemisinin derivatives
Gary H Posner, Wonsuk Chang, Lindsey Hess, et al.
The Journal of Surgical Research
|
May 21, 2026
Risks for Recurrence After Pediatric Primary Spontaneous Pneumothorax: Results From a Multicenter Study
Abigail J Engwall-Gill, Katrina Morgan, Jennine H Weller, et al.
Page
of 7